The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
NMDA receptors in nervous system diseases
Open accessAbstract
NMDA receptor (NMDAR) dysfunction has emerged as a common theme in several major nervous system disorders, including ischemic brain injury, chronic neurodegenerative diseases, pain, depression and schizophrenia. Either hyperactivity or hypofunction of NMDARs could contribute to disease pathophysiology. It is likely that distinct subtypes of NMDARs (as defined by subunit composition and/or subsynaptic location) are differentially involved in central nervous system diseases. Here we focus on a few examples of nervous system diseases where the contribution of NMDARs is relatively well characterized and discuss the implications for potential treatment of these illnesses. This article is part of the Special Issue entitled 'Glutamate Receptor-Dependent Synaptic Plasticity'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 2×
“NMDARs containing different GluN2A-D subunits exhibit distinct electrophysiological and pharmacological properties and somewhat different distribution and expression profiles (Cull-Candy and Leszkiewicz, 2004; Paoletti and Neyton, 2007; Traynelis et al., 2010).”
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“ketamine in animals but the target identified was BDNF rather than mTOR (Autry et al., 2011).”
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 3×
“Furthermore blocking the interaction between GluN2B and PSD-95 with a synthetic peptide in vivo improved memory functions and reduced premature death in ADmice (Ittner et al., 2010).”
Ionic dependence of glutamate neurotoxicity
Choi, D. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,802
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 4×
“…2002;HardinghamandBading, 2010). ba Localization Model Sub Stimulating synaptic NMDARs activates cAMP response elementbinding protein (CREB) signaling and promotes survival, while activation of extrasynaptic NMDARs attenuates CREB signaling and promotes cell death (Hardingham and Bading, 2010).”
InfluentialShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Self-citationHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · cited 1×
“…provide a satisfactory account of the pathophysiology underlying negative symptoms and cognitive deficits, which are not treated effectively by dopamine receptor antagonists and which are increasingly recognized as the core deficits in schizophrenia (Moghaddam and Javitt, 2012; Lewis et al., 2012).”
The Toxic Effect of Sodium L-Glutamate on the Inner Layers of the Retina
LUCAS, D. R., & NEWHOUSE, J. P. (1957) · Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010205006 · Cited by 1,063
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917 · cited 4×
“Clinical trials with glycine or D-serine (which target the glycine co-agonist site in NMDARs) aiming to enhance the activity and function of the glutamate system have produced mixed results (Coyle, 2006; Lindsley et al., 2006).”
InfluentialNMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Role of Distinct NMDA Receptor Subtypes at Central Synapses
Cull-Candy, S. G., & Leszkiewicz, D. N. (2004) · Science's STKE · doi:10.1126/stke.2552004re16 · Cited by 804
Tovar, K. R., & Westbrook, G. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04180.1999 · Cited by 786
Src kinases: a hub for NMDA receptor regulation
Salter, M. W., & Kalia, L. V. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1368 · Cited by 776
Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0116-07.2007 · Cited by 773
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J.-P., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 754
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752
Developmental changes in distribution of NMDA receptor channel subunit mRNAs
Watanabe, M., Inoue, Y., Sakimura, K., & Mishina, M. (1992) · NeuroReport · doi:10.1097/00001756-199212000-00027 · Cited by 719
Li, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0203-11.2011 · Cited by 671
The Postsynaptic Organization of Synapses
Sheng, M., & Kim, E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005678 · Cited by 603
Self-citationFactors affecting excitatory amino acid release following severe human head injury
Bullock, R., Zauner, A., Woodward, J. J., Myseros, J., Choi, S. C., Ward, J. D., Marmarou, A., & Young, H. F. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.4.0507 · Cited by 526
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Excitotoxicity and the NMDA receptor -- still lethal after eight years
Rothman, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93869-y · Cited by 508
Roles of NMDA NR2B Subtype Receptor in Prefrontal Long-Term Potentiation and Contextual Fear Memory
Zhao, M.-G., Toyoda, H., Lee, Y.-S., Wu, L.-J., Ko, S. W., Zhang, X.-H., Jia, Y., Shum, F., Xu, H., Li, B.-M., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.014 · Cited by 495
Kim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494
Self-citationDAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M. M., Belal, C., Wang, M., Jia, N., Zhang, W., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.055 · Cited by 493
Molecular basis of NMDA receptor functional diversity
Paoletti, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07628.x · Cited by 451
Synapses and Alzheimer's Disease
Sheng, M., Sabatini, B. L., & Sudhof, T. C. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005777 · Cited by 436 · cited 1×
“It is widely believed that soluble oligomeric forms of amyloid-b (Ab) perturb synaptic function and plasticity (Sheng et al., 2012).”
Self-citationOkamoto, S.-I., Pouladi, M. A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 436
Luo, J., Wang, Y., Yasuda, R. P., Dunah, A. W., & Wolfe, B. B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.79 · Cited by 401
Hill, M. D., Martin, R. H., Mikulis, D., Wong, J. H., Silver, F. L., terBrugge, K. G., Milot, G., Clark, W. M., MacDonald, R. L., Kelly, M. E., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70225-9 · Cited by 400
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Jernigan, C. S., Goswami, D. B., Austin, M. C., Iyo, A. H., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.010 · Cited by 386
Leonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., & Hell, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3239 · Cited by 385
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 379
Understanding LTP in Pain Pathways
Sandkühler, J. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-9 · Cited by 358
Boyce, S., Wyatt, A., Webb, J. K., O’Donnell, R., Mason, G., Rigby, M., Sirinathsinghji, D., Hill, R. G., & Rupniak, N. M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00218-4 · Cited by 342
Genetic enhancement of inflammatory pain by forebrain NR2B overexpression
Wei, F., Wang, G.-D., Kerchner, G. A., Kim, S. J., Xu, H.-M., Chen, Z.-F., & Zhuo, M. (2001) · Nature Neuroscience · doi:10.1038/83993 · Cited by 330
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · cited 1×
“Inhibition of NMDAR function led to decreased expression of parvalbumin in parvalbumin-containing inhibitory neurons, with GluN2Apreferring antagonist being more effective than GluN2B antagonist (Kinney et al., 2006).”
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease
Milnerwood, A. J., & Raymond, L. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.08.002 · Cited by 312
Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
Jo, J., Whitcomb, D. J., Olsen, K. M., Kerrigan, T. L., Lo, S.-C., Bru-Mercier, G., Dickinson, B., Scullion, S., Sheng, M., Collingridge, G., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2785 · Cited by 305
Self-citationLack of NMDA Receptor Subtype Selectivity for Hippocampal Long-Term Potentiation
Berberich, S., Punnakkal, P., Jensen, V., Pawlak, V., Seeburg, P. H., Hvalby, Ø., & Köhr, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1905-05.2005 · Cited by 302
Rauner, C., & Köhr, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182600 · Cited by 275
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271
NMDA Di-Heteromeric Receptor Populations and Associated Proteins in Rat Hippocampus
Al-Hallaq, R. A., Conrads, T. P., Veenstra, T. D., & Wenthold, R. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2155-07.2007 · Cited by 247
Rönicke, R., Mikhaylova, M., Rönicke, S., Meinhardt, J., Schröder, U. H., Fändrich, M., Reiser, G., Kreutz, M. R., & Reymann, K. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.011 · Cited by 247
Neyton, J., & Paoletti, P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5242-05.2006 · Cited by 243
Differential Roles of NMDA Receptor Subtypes in Ischemic Neuronal Cell Death and Ischemic Tolerance
Chen, M., Lu, T.-J., Chen, X.-J., Zhou, Y., Chen, Q., Feng, X.-Y., Xu, L., Duan, W.-H., & Xiong, Z.-Q. (2008) · Stroke · doi:10.1161/strokeaha.108.521898 · Cited by 242
Biegon, A., Fry, P. A., Paden, C. M., Alexandrovich, A., Tsenter, J., & Shohami, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305741101 · Cited by 238
Modulation of Triheteromeric NMDA Receptors by N-Terminal Domain Ligands
Hatton, C. J., & Paoletti, P. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.005 · Cited by 237
Deshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232
Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain
Wu, L.-J., & Zhuo, M. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.008 · Cited by 199
Bordji, K., Becerril-Ortega, J., Nicole, O., & Buisson, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3021-10.2010 · Cited by 197
Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain
Qu, X.-X., Cai, J., Li, M.-J., Chi, Y.-N., Liao, F.-F., Liu, F.-Y., Wan, Y., Han, J.-S., & Xing, G.-G. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.10.018 · Cited by 182
A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function
Wang, C.-C., Held, R. G., Chang, S.-C., Yang, L., Delpire, E., Ghosh, A., & Hall, B. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.023 · Cited by 180
Hoey, S. E., Williams, R. J., & Perkinton, M. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6017-08.2009 · Cited by 178
Stroke intervention pathways: NMDA receptors and beyond
Lai, T. W., Shyu, W.-C., & Wang, Y. T. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.008 · Cited by 178
The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults
Martel, M.-A., Ryan, T. J., Bell, K. F. S., Fowler, J. H., McMahon, A., Al-Mubarak, B., Komiyama, N. H., Horsburgh, K., Kind, P. C., Grant, S. G. N., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.021 · Cited by 176
Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand
Soriano, F. X., Martel, M., Papadia, S., Vaslin, A., Baxter, P. S., Rickman, C., Forder, J. P., Tymianski, M., Duncan, R. R., Aarts, M. M., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1207-08.2008 · Cited by 175
Pharmacology of Traumatic Brain Injury: Where Is the “Golden Bullet”?
Beauchamp, K., Mutlak, H., Smith, W. R., Shohami, E., & Stahel, P. F. (2008) · Molecular Medicine · doi:10.2119/2008-00050.beauchamp · Cited by 173
Weitlauf, C., Honse, Y., Auberson, Y. P., Mishina, M., Lovinger, D. M., & Winder, D. G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2388-05.2005 · Cited by 170
Abe, T., Matsumura, S., Katano, T., Mabuchi, T., Takagi, K., Xu, L., Yamamoto, A., Hattori, K., Yagi, T., Watanabe, M., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04340.x · Cited by 167
Survival Signaling Pathways Activated by NMDA Receptors
Hetman, M., & Kharebava, G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057553 · Cited by 164
Rammes, G., Hasenjäger, A., Sroka-Saidi, K., Deussing, J. M., & Parsons, C. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.051 · Cited by 163
PTEN is recruited to the postsynaptic terminal for NMDA receptor‐dependent long‐term depression
Jurado, S., Benoist, M., Lario, A., Knafo, S., Petrok, C. N., & Esteban, J. A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.160 · Cited by 161
Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia
Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156
Alzheimer's disease amyloid β-protein and synaptic function
Ondrejcak, T., Klyubin, I., Hu, N.-W., Barry, A. E., Cullen, W. K., & Rowan, M. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8091-0 · Cited by 146
Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit
Nozaki, C., Vergnano, A. M., Filliol, D., Ouagazzal, A., Goff, A. L., Carvalho, S., Reiss, D. J., Gavériaux‐Ruff, C., Neyton, J., Paoletti, P., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2844 · Cited by 143
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-71 · Cited by 137
Marvizón, J. C. G., McRoberts, J. A., Ennes, H. S., Song, B., Wang, X., Jinton, L., Corneliussen, B., & Mayer, E. A. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10202 · Cited by 134
Amyloid-β Induces Caspase-Dependent Loss of PSD-95 and Synaptophysin Through NMDA Receptors
Liu, J., Chang, L., Roselli, F., Almeida, O. F. X., Gao, X., Wang, X., Yew, D. T. W., & Wu, Y. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100948 · Cited by 133
New developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Heng, M. Y., Detloff, P. J., Wang, P. L., Tsien, J. Z., & Albin, R. L. (2008) · Nature Precedings · doi:10.1523/jneurosci.5599-08.2009 · Cited by 131
Frizelle, P. A., Chen, P. E., & Wyllie, D. J. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024042 · Cited by 128
Contributions of the d-serine pathway to schizophrenia
Labrie, V., Wong, A. H. C., & Roder, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.030 · Cited by 127
Cook, D. J., Teves, L. M., & Tymianski, M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003824 · Cited by 119
Activation of NR2A Receptors Induces Ischemic Tolerance through CREB Signaling
Terasaki, Y., Sasaki, T., Yagita, Y., Okazaki, S., Sugiyama, Y., Oyama, N., Omura‐Matsuoka, E., Sakoda, S., & Kitagawa, K. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.18 · Cited by 98
Chen, M.-H., Bullock, R. M., Graham, D. I., Miller, J. D., & McCulloch, J. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.6.0944 · Cited by 95
Wilson, J. A., Garry, E. M., Anderson, H. A., Rosie, R., Colvin, L., Mitchell, R., & Fleetwood-Walker, S. M. (2005) · Pain · doi:10.1016/j.pain.2005.07.005 · Cited by 90
Short Therapeutic Window for MK-801 in Transient Focal Cerebral Ischemia in Normotensive Rats
Margaill, I., Parmentier, S., Callebert, J., Allix, M., Boulu, R. G., & Plotkine, M. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00013 · Cited by 85
Matsumura, S., Kunori, S., Mabuchi, T., Katano, T., Nakazawa, T., Abe, T., Watanabe, M., Yamamoto, T. S., Okuda‐Ashitaka, E., & Ito, S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07348.x · Cited by 75
Niesters, M., & Dahan, A. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.712686 · Cited by 66
Jocoy, E. L., André, V. M., Cummings, D. M., Rao, S. P., Wu, N., Ramsey, A. J., Caron, M. G., Cepeda, C., & Levine, M. S. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00028 · Cited by 58
Karlsson, U., Sjödin, J., Möller, K. Ä., Johansson, S., Wikström, L., & Näsström, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00140-9 · Cited by 48
Spinal cord long‐term potentiation is attenuated by the NMDA‐2B receptor antagonist Ro 25‐6981
Pedersen, L. M., & Gjerstad, J. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01756.x · Cited by 45
Yang, Y., Li, Q., Yang, T., Hussain, M., & Shuaib, A. M. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.2.0397 · Cited by 25
Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease
Tallaksen‐Greene, S. J., Janiszewska, A., Benton, K., Ruprecht, L., & Albin, R. L. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.015 · Cited by 23
Cited by
Nitric oxide signaling in health and disease
Lundberg, J. O., & Weitzberg, E. (2022) · Cell · doi:10.1016/j.cell.2022.06.010 · Cited by 826
Kamat, P. K., Kalani, A., Rai, S., Swarnkar, S., Tota, S., Nath, C., & Tyagi, N. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9053-6 · Cited by 500
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 275
Reelin and neuropsychiatric disorders
Ishii, K., Kubo, K.-I., & Nakajima, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00229 · Cited by 185
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
“NMDAR dysfunction has long been thought to have a paramount role in a variety of neurological disorders, ranging from acute (e.g. stroke and global cerebral ischaemia) to chronic disorders such as Alzheimer's or Huntington's disease (Zhou & Sheng, 2013; Ittner & Gotz, 2011).”
Background
Metadata
- Authors
- Zhou, Q., & Sheng, M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 74
- Pages
- 69-75
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2107099794
- Cited by
- 298
- References
- 100
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.